Astera Labs (NASDAQ:ALAB) Given New $300.00 Price Target at TD Cowen

Astera Labs (NASDAQ:ALAB) had its price target lowered by TD Cowen from $375.00 to $300.00 in a research report released on Monday morning,Benzinga reports. The brokerage currently has a hold rating on the stock.

A number of other research analysts also recently commented on ALAB. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Morgan Stanley upped their price objective on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, October 9th. Needham & Company LLC lifted their price objective on shares of Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada upped their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $344.17.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $286.58 on Monday. The business’s 50-day simple moving average is $314.24 and its 200 day simple moving average is $299.64. Astera Labs has a one year low of $97.89 and a one year high of $499.48. The company has a market cap of $49.72 billion, a P/E ratio of 141.87 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts predict that Astera Labs will post 2.70 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 408,558 shares of company stock valued at $127,306,034 in the last ninety days. Company insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Institutional investors have recently added to or reduced their stakes in the business. Net Worth Advisory Group acquired a new position in Astera Labs in the 3rd quarter valued at $1,032,000. Sumitomo Mitsui DS Asset Management Company Ltd raised its holdings in Astera Labs by 6.1% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 25,520 shares of the company’s stock valued at $9,084,000 after acquiring an additional 1,464 shares in the last quarter. Teamwork Financial Advisors LLC raised its stake in shares of Astera Labs by 32.5% in the third quarter. Teamwork Financial Advisors LLC now owns 5,246 shares of the company’s stock valued at $1,867,000 after purchasing an additional 1,287 shares in the last quarter. Frank Rimerman Advisors LLC lifted its holdings in shares of Astera Labs by 6.2% during the 3rd quarter. Frank Rimerman Advisors LLC now owns 2,639 shares of the company’s stock worth $939,000 after acquiring an additional 154 shares during the period. Finally, Encompass More Asset Management bought a new position in Astera Labs during the third quarter worth about $886,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.